Clinical trial
Benefit of Lidocaine Perfusion in Cancer Related Visceral Pain Resistant to…
NCT00181012 · Gustave Roussy, Cancer Campus, Grand Paris, Other · Unknown status
Key facts
| NCT number | NCT00181012 |
|---|---|
| Title | Benefit of Lidocaine Perfusion in Cancer Related Visceral Pain Resistant to Morphinics |
| Official title | Benefit of Lidocaine Perfusion in Cancer Related Visceral Pain Resistant to Morphinics: Efficacy Study in Adults and Children. Randomized Prospective Study With Direct Individual Benefit |
| Lead sponsor | Gustave Roussy, Cancer Campus, Grand Paris, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cancer, Pain |
| Intervention type | Drug |
| Interventions | Lidocaine |
| Enrollment | 100 |
| Start date | May 1, 2005 |
| First posted | Sep 16, 2005 |
| Last update posted | Sep 19, 2007 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: